| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acknowledgement to Referees
|
|
|
|
17 |
6 |
p. 611-614
|
article
|
| 2 |
Addressing Challenges and Controversies in the Management of Prostate Cancer with Multidisciplinary Teams
|
Shore, Neal D.
|
|
|
17 |
6 |
p. 709-725
|
article
|
| 3 |
Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
|
Niizeki, Takashi
|
|
|
17 |
6 |
p. 643-653
|
article
|
| 4 |
Do Early Phase Oncology Trials Predict Clinical Efficacy in Subsequent Biomarker-Enriched Phase III Randomized Trials?
|
Udayakumar, Suji
|
|
|
17 |
6 |
p. 665-674
|
article
|
| 5 |
Dutch Gastrointestinal Stromal Tumor (GIST) Registry Data Comparing Sunitinib with Imatinib Dose Escalation in Second-Line Advanced Non-KIT Exon 9 Mutated GIST Patients
|
Mohammadi, Mahmoud
|
|
|
17 |
6 |
p. 627-634
|
article
|
| 6 |
Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study
|
Akli, Assya
|
|
|
17 |
6 |
p. 675-682
|
article
|
| 7 |
Methods for Estimating Long-Term Outcomes for Trastuzumab Deruxtecan in HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies
|
Dunton, Kyle
|
|
|
17 |
6 |
p. 655-663
|
article
|
| 8 |
Mutational Landscape and Expression of PD-L1 in Patients with Non-Small Cell Lung Cancer Harboring Genomic Alterations of the MET gene
|
Fischer, Alessa
|
|
|
17 |
6 |
p. 683-694
|
article
|
| 9 |
Prediction of Resistance Mutations Against Upcoming Anaplastic Lymphoma Kinase Inhibitors
|
Doi, Yuta
|
|
|
17 |
6 |
p. 695-707
|
article
|
| 10 |
Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer
|
Arrichiello, Gianluca
|
|
|
17 |
6 |
p. 635-642
|
article
|
| 11 |
Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2− Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study
|
De Laurentiis, Michelino
|
|
|
17 |
6 |
p. 615-625
|
article
|
| 12 |
Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
|
Lee, Arnold
|
|
|
17 |
6 |
p. 727-733
|
article
|
Journal description